|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-6-29
|
|
pubmed:abstractText |
Cytomegalovirus (CMV) infections are common after lung transplantation (LuTx) and have an influence on acute rejection rates and chronic organ dysfunction. The objective of this study was to determine the incidence of CMV infections by comparing a prolonged valganciclovir prophylaxis with a standard regimen in high-risk LuTx recipients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1557-3117
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
670-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19560694-Administration, Oral,
pubmed-meshheading:19560694-Adult,
pubmed-meshheading:19560694-Antiviral Agents,
pubmed-meshheading:19560694-Cytomegalovirus,
pubmed-meshheading:19560694-Cytomegalovirus Infections,
pubmed-meshheading:19560694-Female,
pubmed-meshheading:19560694-Ganciclovir,
pubmed-meshheading:19560694-Humans,
pubmed-meshheading:19560694-Incidence,
pubmed-meshheading:19560694-Kaplan-Meier Estimate,
pubmed-meshheading:19560694-Lung,
pubmed-meshheading:19560694-Lung Transplantation,
pubmed-meshheading:19560694-Male,
pubmed-meshheading:19560694-Middle Aged,
pubmed-meshheading:19560694-Retrospective Studies,
pubmed-meshheading:19560694-Risk Factors,
pubmed-meshheading:19560694-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.
|
|
pubmed:affiliation |
Department of Cardio-thoracic Surgery, General Hospital Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
